Zotizalkib

• Description:

  Zotizalkib (TPX-0131) is an orally active and selective ALK inhibitor with antitumor activity for the study of non-small cell lung cancer.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  447.41

• Molecular Formula:

  C21H20F3N5O3

• Notes:

  Research use only, not for human use.

• Receptor:

  ALK

• CAS Number:

  2648641-36-3